Investing in Therapies that Accelerate Health Equity - PowerPoint PPT Presentation

About This Presentation
Title:

Investing in Therapies that Accelerate Health Equity

Description:

Syridex Bio is an impact-driven, life sciences-focused firm investing in therapies that address the needs of underserved communities. – PowerPoint PPT presentation

Number of Views:1
Updated: 14 February 2023
Slides: 9
Provided by: syridexbio
Category: Other
Tags:

less

Transcript and Presenter's Notes

Title: Investing in Therapies that Accelerate Health Equity


1
  • Syridex Bio is an impact-driven, life
    sciences-focused firm investing in therapies that
    accelerate global health equity by addressing the
    needs of underserved communities. Syridex Bio was
    founded on the belief that everyone deserves the
    opportunity to live a healthy life. For too long,
    deep inequities have persisted across our
    pharmaceutical, biotechnology, and medical
    systems. Despite increased public attention on
    the problem in recent years, progress remains far
    too slow. At Syridex Bio, we are addressing this
    gap in the market by strategically investing in
    therapies that treat diseases disproportionately
    affecting minoritized communities. By financing
    the development of drugs and treatments
    addressing the worlds greatest health
    disparities, we are convinced that we can
    accelerate health equity globally and achieve
    strong financial returns for our investors.

2
TeamMeet the leaders guiding our work
3
ApproachApproachExplore our investment
philosophy and strategy
4
About Us
  • Syridex Bio was founded on the belief that
    everyone deserves the opportunity to live a
    healthy life. For too long, deep inequities have
    persisted across our pharmaceutical,
    biotechnology, and medical systems. Despite
    increased public attention on the problem in
    recent years, progress remains far too slow. 
  • At Syridex Bio, we are addressing this gap in the
    market by strategically investing in therapies
    that treat diseases disproportionately affecting
    underserved communities. By financing the
    development of drugs and treatments addressing
    the worlds greatest health disparities, we are
    convinced that we can accelerate health equity
    globally and achieve strong financial returns for
    our investors.

5
Founding Investment Team
Squire ServanceREAD BIO
6
Advisory Board
Anindya Roychowdhury READ BIO
Owen May READ BIO
Veleka Peeples-Dyer READ BIO
Kamil Ali-Jackson READ BIO
Kelvin A. Baggett, MD READ BIO
7
Investment Approach

Investment Focus We draw on our deep
relationships across the global pharmaceutical
and biotech industries to source innovative,
best-in-class clinical stage or near-clinical
stage therapies for diseases that
disproportionately affect underserved
communities. Then, we invest in development to
bring to market novel drugs and treatments that
might otherwise go undeveloped.  Investment
Strategy We invest along two primary strategies
venture creation and private equity. Venture
Creation Building sustainable companies around
innovative products we acquire from life sciences
companies and institutions Private Equity
Privatizing and creating value for undervalued
public pharmaceutical and biotechnology
companies Investment Team Our team is focused on
accelerating health equity and eliminating health
disparities around the world. MEET OUR TEAM
8
Contact Us info_at_syridexbio.com 300 Carnegie
Center, Suite 150, Princeton, NJ 08540
Write a Comment
User Comments (0)
About PowerShow.com